TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.63, no.2, pp.94-101, 2015 (ESCI)
Introduction: For hospitalized patients, monotherapy with a respiratory Fluoroquinolone (F) and dual therapy combination a ampicilline-sulbactam + a macrolide (AS+ M) are extensively used in the treatment of community-acquiredpneumonia (CAP). In this study, empirical AS + M combination therapy versus F monotherapy was compared in hospitalized adult CAP patients.